Login Register Cart 0
Generic placeholder image

Cardiovascular & Hematological Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5257
ISSN (Online): 1875-6182

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Preparation and Evaluation of ‘3 Cap’ Pulsatile Drug Delivery System of Ramipril

Author(s): Priyanka Kriplani*, Kamla Pathak and Anil Philip

Volume 19, Issue 1, 2021

Published on: 28 May, 2020

Page: [50 - 61] Pages: 12

DOI: 10.2174/1871525718666200528140527

Price: $65

Abstract

Background: Chronotherapeutics, the drug delivery based on circadian rhythm, is recently gaining much attention worldwide. Various diseases like asthma, hypertension, and arthritis show the circadian variation that demands time scheduled drug release for effective drug action. Therefore, the pulsatile drug delivery system has been designed to confer preprogrammed drug delivery.

Objective: In the present study, a ‘3 Cap’ pulsatile drug delivery system has been developed, optimized, and characterized in order to achieve the floating and pulsatile release of ramipril.

Methods: An optimal response surface design was employed to investigate the effect of isopropanol: formaldehyde vapors for varying time on drug release from the capsules. ‘3 Cap’ pulsatile drug delivery system was evaluated in terms of floating time, density, the effect of gastric flow rate, and type of dissolution apparatus on drug release.

Results: Independent variables exhibited a significant effect on the drug release of the prepared formulations. Results showed that time between the release of fractions of dose increased with an increase in formaldehyde: isopropanol ratio and duration of exposure to formaldehyde vapors with no effect of gastric flow rate.

Conclusion: The results of the designed system revealed that an optimum exposure of 1:2 of isopropanol: formaldehyde vapors for sixty minutes resulted in the desired release of second pulse of dose after a predetermined lag time of 5 hours as desired. ‘3Cap’ system was successful in achieving floating and pulsed release of hypertensive drug opening a ‘new lease of life’ to the existing drug molecule.

Keywords: Capsule, chronotherapeutics, drug delivery system, floating, lag time, optimization, preprogrammed, pulsatile, ramipril.

« Previous Next »
Graphical Abstract

[1]
Savkare, D.A.; Pagar, S.P. Comparison of various approaches to increase the gastric residense time. Int. J. Pharm. Sci. Res., 2017, 8(6), 2388-2395.
[2]
Jain, S.K.; Awasthi, A.M.; Jain, N.K.; Agrawal, G.P. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: preparation and in vitro characterization. J. Cont. Rel., 2005, 107(2), 300-309.
[http://dx.doi.org/10.1016/j.jconrel.2005.06.007] [PMID: 16095748]
[3]
Karavas, E.; Georgarakis, E.; Bikiaris, D. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur. J. Pharm. Biopharm., 2006, 64(1), 115-126.
[http://dx.doi.org/10.1016/j.ejpb.2005.12.013] [PMID: 16675210]
[4]
Sharma, S.; Pawar, A. Low density multiparticulate system for pulsatile release of meloxicam. Int. J. Pharm., 2006, 313(1-2), 150-158.
[http://dx.doi.org/10.1016/j.ijpharm.2006.02.001] [PMID: 16540268]
[5]
Sungthongjeen, S.; Puttipipatkhachorn, S.; Paeratakul, O.; Dashevsky, A.; Bodmeier, R. Development of pulsatile release tablets with swelling and rupturable layers. J. Cont. Rel., 2004, 95(2), 147-159.
[http://dx.doi.org/10.1016/j.jconrel.2003.10.023] [PMID: 14980764]
[6]
Remko, M. Acidity, lipophilicity, solubility, absorption, and polar surface area of some ACE inhibitors. Chem. Pap. Slovak Acad. Sci., 2007, 61(2), 133-141.
[http://dx.doi.org/10.2478/s11696-007-0010-y]
[7]
Hanysová, L.; Václavková, M.; Dohnal, J.; Klimes, J. Stability of ramipril in the solvents of different pH. J. Pharm. Biomed. Anal., 2005, 37(5), 1179-1183.
[http://dx.doi.org/10.1016/j.jpba.2004.10.041] [PMID: 15862704]
[8]
European Pharmacopoeia. Published by Directorate for the quality of medicines of the council of Europe, 5th ed; , 2005, Vol. 2, pp. 2355-2356.
[9]
Diego, D.M.; Godoy, G.; Mennickent, S.; Olivare, M.; Godoy, R. Stress degradation studies of ramipril by a validated stability-indicating liquid chromatographic method. J. Chil. Chem. Soc., 2010, 55(4), 450-453.
[http://dx.doi.org/10.4067/S0717-97072010000400008]
[10]
Boltan, S. Pharmaceutical Statistics. 3rd ed.; Marcel Dekker Inc: New York; , 2003, 80, pp. 265-490.
[http://dx.doi.org/10.1201/9780203912799]
[11]
Ahmed, T.A.; El-Say, K.M. Transdermal film-loaded finasteride microplates to enhance drug skin permeation: Two-step optimization study. Eur. J. Pharm. Sci., 2016, 88, 246-256.
[http://dx.doi.org/10.1016/j.ejps.2016.03.015] [PMID: 26993962]
[12]
Parhi, R.; Suresh, P. Formulation optimization and characterization of transdermal film of simvastatin by response surface methodology. Mater. Sci. Eng. C, 2016, 58, 331-341.
[http://dx.doi.org/10.1016/j.msec.2015.08.056] [PMID: 26478318]
[13]
Mesbah, Oskui S.; Bhakta, H.C.; Diamante, G.; Liu, H.; Schlenk, D.; Grover, W.H. Measuring the mass, volume, and density of microgram-sized objects in fluid. PLoS One, 2017, 12(4)e0174068
[http://dx.doi.org/10.1371/journal.pone.0174068] [PMID: 28379982]
[14]
Najmuddin, M.; Patel, A.V.; Ali, A.; Shelar, S.; Tausif, K. Development and evaluation of pulsatile drug delivery system of Flubiprofen. Res. J. Pharm. Biol. Chem. Sci., 2010, 1(2), 284-290.
[15]
Bhise, S.B.; Aloorkar, N.H. Formulation and in vitro evaluation of floating capsules of theophylline. Indian J. Pharm. Sci., 2008, 70(2), 224-227.
[http://dx.doi.org/10.4103/0250-474X.41460] [PMID: 20046717]
[16]
Anand, O.; Yu, L.X.; Conner, D.P.; Davit, B.M. Dissolution testing for generic drugs: An FDA perspective. AAPS J., 2011, 13(3), 328-335.
[http://dx.doi.org/10.1208/s12248-011-9272-y] [PMID: 21479700]
[17]
Collegen, I. The protein-formaldehyde reaction. J. Biol. Chem., 2009, 1, 87-97.
[18]
Ozer, A.Y.; Hincal, A.A. Studies on the masking of unpleasant taste of beclamide: Microencapsulation and tabletting. J. Microencapsul., 1990, 7(3), 327-339.
[http://dx.doi.org/10.3109/02652049009021843] [PMID: 2384836]

Rights & Permissions Print Cite
Article Metrics
9
1
© 2024 Bentham Science Publishers | Privacy Policy